Cargando…
Personalising and targeting antiangiogenic resistance: a complex and multifactorial approach
Pathological angiogenesis involves complex and dynamic interactions between tumour cells and other lineages existing in the microenvironment of the tumour. Preclinical and clinical data suggest that tumours can show dual, different adaptive responses against antiangiogenic agents: one successful ada...
Autores principales: | Bueno, Maria J, Mouron, Silvana, Quintela-Fandino, Miguel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5418445/ https://www.ncbi.nlm.nih.gov/pubmed/28301873 http://dx.doi.org/10.1038/bjc.2017.69 |
Ejemplares similares
-
Monitoring vascular normalization: new opportunities for mitochondrial inhibitors in breast cancer
por: Mouron, Silvana, et al.
Publicado: (2021) -
Monitoring vascular normalization induced by antiangiogenic treatment with 18F‐fluoromisonidazole‐PET
por: Hernández-Agudo, Elena, et al.
Publicado: (2015) -
FGFR1 amplification or overexpression and hormonal resistance in luminal breast cancer: rationale for a triple blockade of ER, CDK4/6, and FGFR1
por: Mouron, Silvana, et al.
Publicado: (2021) -
Usefulness and real-world outcomes of next generation sequencing testing in patients with cancer: an observational study on the impact of selection based on clinical judgement
por: Colomer, Ramon, et al.
Publicado: (2023) -
Nintedanib plus letrozole in early breast cancer: a phase 0/I pharmacodynamic, pharmacokinetic, and safety clinical trial of combined FGFR1 and aromatase inhibition
por: Quintela-Fandino, Miguel, et al.
Publicado: (2019)